Skip to main content

Table 2 Baseline characteristics of the subjects

From: Analysis of renin-angiotensin aldosterone system gene polymorphisms in malaysian essential hypertensive and type 2 diabetic subjects

Parameters Group 1
(n-70)
Group 2
(n-60)
Group 3
(n-65)
Group 4
(n-75)
Gender
(male/female)
51/19* 33/27 40/25 39/36
Age
(Years)
57.70 ± 11.02* 57.70 ± 10.24* 57.61 ± 9.76* 45.37 ± 10.69
BMI
(kg/m2)
25.63 ± 4.15* 27.89 ± 3.93* 26.71 ± 3.59* 23.91 ± 4.01
SBP
(mm Hg)
159.44 ± 17.10* 125.93 ± 9.05 160.26 ± 19.01* 125.98 ± 8.81
DBP
(mm Hg)
96.40 ± 6.52* 74.97 ± 7.34 93.60 ± 3.77* 77.83 ± 7.09
FPG
(mmol/L)
5.24 ± 0.54* 11.85 ± 4.81* 11.68 ± 4.71* 4.60 ± 0.91
HDL-C
(mmol/L)
0.86 ± 0.31* 0.73 ± 0.22* 0.78 ± 0.29* 1.11 ± 0.40
LDL-C
(mmol/L)
3.42 ± 1.09 4.04 ± 1.47* 3.76 ± 1.19 3.36 ± 1.16
TG
(mmol/L))
1.97 ± 0.99 2.09 ± 1.01* 1.95 ± 0.87 1.64 ± 0.98
TC
(mmol/L
4.80 ± 1.10 5.14 ± 1.31 5.05 ± 1.26 5.12 ± 1.38
Na
(mEq/L)
144.17 ± 12.78* 133.01 ± 9.60* 137.12 ± 10.11* 114.73 ± 18.38
K
(mEq/L)
4.94 ± 1.15 4.90 ± 0.82 5.24 ± 0.92 5.13 ± 0.89
  1. Data presented as mean ± SD, Group 1- EHT, Group 2 -T2DM, Group 3-EHT+T2DM and Group 4-Control subjects,* P value < 0.05 vs. Group 4